Classification of New Biomarkers of Dilated Cardiomyopathy Based on Pathogenesis

Journals Menu

Follow SCIRP

ISSN Print: 1949-4998
ISSN Online: 1949-5005
www.scirp.org/journal/health
E-mail: health@scirp.org

"Classification of New Biomarkers of Dilated Cardiomyopathy Based on Pathogenesis—An Update"
written by Muhammad Nabeel Dookhun, Yali Sun, Huayiyang Zou, Xiaoqian Cao, Xinzheng Lu,
published by Health, Vol.10 No.3, 2018

has been cited by the following article(s):

[1]	Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy
	2021

[2]	血清白蛋白水平对扩张型心肌病患者心功能衰竭程度及猝死风险的预测价值
	2020

[3]	Potential Genetic Biomarkers for Dilated Cardiomyopathy Using Genomic Data
	2020

[4]	Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
	Frontiers in Molecular Biosciences, 2019

[5]	Correlation between myocardial myosin-binding protein C, hypertension with left ventricular enlargement, and dilated cardiomyopathy
	2019

[6]	Molecular Signatures of Biomarkers with a Special Reference to Stress and Related Diseases/Disorders: Diagnostic, Prognostic and Therapeutic Values-Current …
	2019

[7]	Research Progress of Cardiac Myosin Binding Protein C in Dilated Cardiomyopathy and Other Cardiac Conditions
	2018

[1]	Will “CLINICAL PROTEOMICS” lead to the discovery of new biomarkers for dilated cardiomyopathy (DCM)? Journal of Proteins and Proteomics, 2023 DOI:10.1007/s42485-023-00110-y

[2]	Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy International Journal of Molecular Sciences, 2021 DOI:10.3390/ijms22115688

[3]	Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values Frontiers in Molecular Biosciences, 2019 DOI:10.3389/fmolb.2019.00091

Follow SCIRP